{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:35:13Z","timestamp":1793115313784,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2738,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1111\/j.1469-0691.2007.01681.x","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T03:24:02Z","timestamp":1170473042000},"page":"560-578","source":"Crossref","is-referenced-by-count":455,"title":["Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium"],"prefix":"10.1016","volume":"13","author":[{"given":"N.","family":"Mesaros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pl\u00e9siat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roussel-Delvallez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Van Eldere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Glupczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lebecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Malfroot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01681.x_bib1","series-title":"Principles and practice of infectious diseases","first-page":"2587","article-title":"Pseudomonas aeruginosa","author":"Pier","year":"2005"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.medmal.2005.10.007","article-title":"Targeting mechanisms of Pseudomonas aeruginosa pathogenesis","volume":"36","author":"Kipnis","year":"2006","journal-title":"Med Mal Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tim.2004.08.003","article-title":"Comparative genomic analysis of Pseudomonas aeruginosa virulence","volume":"12","author":"Woods","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2796.2002.01026.x","article-title":"Evolution and spread of antibiotic resistance","volume":"252","author":"Normark","year":"2002","journal-title":"J Intern Med"},{"issue":"suppl 3","key":"10.1111\/j.1469-0691.2007.01681.x_bib6","doi-asserted-by":"crossref","first-page":"S627","DOI":"10.1093\/clinids\/6.Supplement_3.S627","article-title":"Epidemiology of infections due to Pseudomonas aeruginosa","volume":"6","author":"Morrison","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s100960000410","article-title":"Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s","volume":"19","author":"Maschmeyer","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.109.4.1019","article-title":"Ventilator\u2010associated pneumonia due to Pseudomonas aeruginosa","volume":"109","author":"Crouch Brewer","year":"1996","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib9","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/00003246-199711000-00026","article-title":"Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent","volume":"25","author":"Rello","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib10","first-page":"813","article-title":"The role of the intensive care unit environment in the pathogenesis and prevention of ventilator\u2010associated pneumonia","volume":"50","author":"Crnich","year":"2005","journal-title":"Respir Care"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijantimicag.2005.11.005","article-title":"Potentially multidrug\u2010resistant non\u2010fermentative Gram\u2010negative pathogens causing nosocomial pneumonia","volume":"27","author":"Ferrara","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.mcp.0000159834.05401.78","article-title":"Ventilator\u2010associated pneumonia","volume":"11","author":"Shaw","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator\u2010associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01681.x_bib14","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/j.prrv.2006.04.217","article-title":"Diagnosing and managing infection in CF","volume":"7","author":"Ratjen","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.108.4.955","article-title":"Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort","volume":"108","author":"Nicotra","year":"1995","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jinf.2005.06.004","article-title":"Pseudomonas aeruginosa bacteraemia in cancer patients","volume":"52","author":"Krcmery","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib17","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1532-5415.2006.00698.x","article-title":"Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus species: comparison of elderly and nonelderly patients","volume":"54","author":"Marra","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijid.2005.07.003","article-title":"Five years of nosocomial Gram\u2010negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes","volume":"10","author":"Sligl","year":"2006","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/pbc.20441","article-title":"Pseudomonas aeruginosa pre\u2010septal cellulitis and bacteremia in a pediatric oncology patient","volume":"45","author":"Milstone","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib20","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/JCM.43.8.4129-4138.2005","article-title":"Prolonged outbreak of infection due to TEM\u201021\u2010producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home","volume":"43","author":"Dubois","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug\u2010resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1442-2042.2004.00941.x","article-title":"Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations","volume":"11","author":"Hamasuna","year":"2004","journal-title":"Int J Urol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1726-4901(09)70174-1","article-title":"Ear problems in swimmers","volume":"68","author":"Wang","year":"2005","journal-title":"J Chin Med Assoc"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(88)90592-X","article-title":"Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"85","author":"Rubin","year":"1988","journal-title":"Am J Med"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01681.x_bib25","first-page":"S36","article-title":"Pseudomonas keratitis and contact lens wear: the lens\/eye is at fault","volume":"9","author":"Stern","year":"1990","journal-title":"Cornea"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3171\/jns.1969.31.4.0432","article-title":"Infections of the central nervous system due to Pseudomonas aeruginosa","volume":"31","author":"Wise","year":"1969","journal-title":"J Neurosurg"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib27","first-page":"322","article-title":"Mycotic ascending aortic pseudoaneurysm secondary to pseudomonas mediastinitis at the aortic cannulation site","volume":"30","author":"Vrochides","year":"2003","journal-title":"Tex Heart Inst J"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib28","first-page":"137","article-title":"Pseudomonas aeruginosa pseudoaneurysm of the ascending aorta after coronary artery bypass graft surgery","volume":"30","author":"Schmitt","year":"2003","journal-title":"Tex Heart Inst J"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00000658-199308000-00001","article-title":"The gastrointestinal tract. The \u2018undrained abscess\u2019 of multiple organ failure","volume":"218","author":"Marshall","year":"1993","journal-title":"Ann Surg"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01681.x_bib30","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1086\/514909","article-title":"Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram\u2010negative bacteria","volume":"27","author":"Hancock","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2958.2001.02604.x","article-title":"Discovery and distribution of super\u2010integrons among pseudomonads","volume":"42","author":"Vaisvila","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/49.2.229","article-title":"Prescribing guidelines for severe Pseudomonas infections","volume":"49","author":"Giamarellou","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib33","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.amjmed.2006.03.014","article-title":"Resistance in nonfermenting gram\u2010negative bacteria: multidrug resistance to the maximum","volume":"119","author":"McGowan","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.mib.2005.08.014","article-title":"The threat of antibiotic resistance in Gram\u2010negative pathogenic bacteria: beta\u2010lactams in peril","volume":"8","author":"Thomson","year":"2005","journal-title":"Curr Opin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bcp.2005.12.003","article-title":"Redefining penems","volume":"71","author":"Dalhoff","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-0691.2004.00763.x","article-title":"Efflux\u2010mediated multiresistance in Gram\u2010negative bacteria","volume":"10","author":"Poole","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568026013395605","article-title":"Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance","volume":"1","author":"Poole","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib38","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/AAC.41.11.2540","article-title":"Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa","volume":"41","author":"Kohler","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2958.1997.2281594.x","article-title":"Characterization of MexE\u2013MexF\u2013OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa","volume":"23","author":"Kohler","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/AAC.43.6.1340","article-title":"Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa","volume":"43","author":"Lomovskaya","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/AAC.50.4.1347-1351.2006","article-title":"Involvement of the MexXY\u2013OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa","volume":"50","author":"Hocquet","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib42","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/AAC.50.5.1633-1641.2006","article-title":"Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates","volume":"50","author":"Quale","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/48.4.553","article-title":"In vivo selection of a target\/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy","volume":"48","author":"Le Thomas","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","article-title":"High\u2010level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB\u2013OprM efflux pump and the DNA gyrase mutation","volume":"46","author":"Nakajima","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1348-0421.2005.tb03748.x","volume":"49","author":"Niga","year":"2005","journal-title":"Microbiol Immunol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib46","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/AAC.47.8.2385-2392.2003","article-title":"Ambler class A extended\u2010spectrum beta\u2010lactamases in Pseudomonas aeruginosa: novel developments and clinical impact","volume":"47","author":"Weldhagen","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib47","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/AAC.49.9.3743-3748.2005","article-title":"BEL\u20101, a novel clavulanic acid\u2010inhibited extended\u2010spectrum beta\u2010lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa","volume":"49","author":"Poirel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1469-0691.2005.01305.x","article-title":"Pandrug\u2010resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk\u2010factors and outcomes","volume":"12","author":"Wang","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib49","first-page":"1503","article-title":"Epidemiology of extended\u2010spectrum beta\u2010lactamase producing gram\u2010negative bacilli at Siriraj Hospital, Thailand, 2003","volume":"36","author":"Chayakulkeeree","year":"2005","journal-title":"SE Asian J Trop Med Pub Hlth"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijantimicag.2005.09.011","article-title":"Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme 1997\u20132002)","volume":"27","author":"Masterton","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo\u2010beta\u2010lactamases: the quiet before the storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/mdr.2005.11.254","article-title":"Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo\u2010beta\u2010lactamase VIM\u20102 in a hematology unit of a French hospital","volume":"11","author":"Aubron","year":"2005","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/107662902760190635","article-title":"Metallo\u2010beta\u2010lactamase VIM\u20102 in clinical isolates of Pseudomonas aeruginosa from Portugal","volume":"8","author":"Cardoso","year":"2002","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/JCM.41.2.822-825.2003","article-title":"Spread of integron\u2010associated VIM\u2010type metallo\u2010beta\u2010lactamase genes among imipenem\u2010nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals","volume":"41","author":"Giakkoupi","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"suppl 6","key":"10.1111\/j.1469-0691.2007.01681.x_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2005.01264.x","article-title":"The emergence and implications of metallo\u2010beta\u2010lactamases in Gram\u2010negative bacteria","volume":"11","author":"Walsh","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapenemases in Gram\u2010negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","article-title":"Aminoglycosides: activity and resistance","volume":"43","author":"Mingeot\u2010Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2007.01681.x_bib59","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib60","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.43.1.62","article-title":"Type II topoisomerase mutations in ciprofloxacin\u2010resistant strains of Pseudomonas aeruginosa","volume":"43","author":"Mouneimne","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib62","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0140-6736(03)14959-8","article-title":"Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa","volume":"362","author":"Yokoyama","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib63","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF00425655","article-title":"Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin\u2010producer, Micromonospora purpurea","volume":"201","author":"Thompson","year":"1985","journal-title":"Mol Gen Genet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jmb.2006.03.038","article-title":"Aminoglycoside resistance by ArmA\u2010mediated ribosomal 16S methylation in human bacterial pathogens","volume":"359","author":"Liou","year":"2006","journal-title":"J Mol Biol"},{"issue":"suppl 4","key":"10.1111\/j.1469-0691.2007.01681.x_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2005.01161.x","article-title":"Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa","volume":"11","author":"Rossolini","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.qco.0000171920.44809.f0","article-title":"Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting","volume":"18","author":"Navon\u2010Venezia","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug\u2010resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/49.3.561","article-title":"A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended\u2010spectrum beta\u2010lactamase GES\u20102 in South Africa","volume":"49","author":"Poirel","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib69","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/01.CCM.0000069729.06687.DE","article-title":"Strategy of antibiotic rotation: long\u2010term effect on incidence and susceptibilities of Gram\u2010negative bacilli responsible for ventilator\u2010associated pneumonia","volume":"31","author":"Gruson","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib70","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1592\/phco.23.5.618.32197","article-title":"The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta\u2010lactams in a large teaching hospital","volume":"23","author":"Regal","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jhin.2006.04.015","article-title":"Risk factors for the isolation of multi\u2010drug\u2010resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature","volume":"64","author":"Falagas","year":"2006","journal-title":"J Hosp Infect"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2007.01681.x_bib72","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1086\/426189","article-title":"Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections","volume":"40","author":"Burgess","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib73","series-title":"Antimicrobial therapy and vaccines","first-page":"549","article-title":"Pseudomonas aeruginosa","author":"Acharya","year":"2002"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib74","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.38.2.937-937.2000","article-title":"Interference of Pseudomonas strains in the identification of Helicobacter pylori","volume":"38","author":"Dominguez\u2010Bello","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.meegid.2004.01.010","article-title":"The use of molecular typing for epidemiological surveillance and investigation of endemic nosocomial infections","volume":"4","author":"Blanc","year":"2004","journal-title":"Infect Genet Evol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib76","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.2741\/A929","article-title":"Molecular epidemiology of Pseudomonas aeruginosa","volume":"7","author":"Speert","year":"2002","journal-title":"Front Biosci"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib77","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1128\/JCM.26.10.1973-1977.1988","article-title":"Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains","volume":"26","author":"Grothues","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib78","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1128\/JCM.31.9.2320-2326.1993","article-title":"Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients","volume":"31","author":"Struelens","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S0950268800029873","article-title":"Pseudomonas aeruginosa cross\u2010colonization and persistence in patients with cystic fibrosis. Use of a DNA probe","volume":"102","author":"Wolz","year":"1989","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib80","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1164\/rccm.2203011","article-title":"Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada","volume":"166","author":"Speert","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib81","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1365-2672.2005.02691.x","article-title":"Comparative typing of Pseudomonas species isolated from the aquatic environment in Greece by SDS\u2010PAGE and RAPD analysis","volume":"99","author":"Sazakli","year":"2005","journal-title":"J Appl Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.femsim.2004.06.024","article-title":"Population genetic analysis of Pseudomonas aeruginosa using multilocus sequence typing","volume":"43","author":"Vernez","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib83","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1128\/JCM.42.12.5644-5649.2004","article-title":"Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa","volume":"42","author":"Curran","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib84","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1128\/JCM.33.8.2216-2219.1995","article-title":"Comparison of arbitrarily primed PCR and macrorestriction pulsed\u2010field gel electrophoresis typing of Pseudomonas aeruginosa strains from cystic fibrosis patients","volume":"33","author":"Kersulyte","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib85","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jobm.200310264","article-title":"Evaluation of a new agar medium containing cetrimide, kanamycin and nalidixic acid for isolation and enhancement of pigment production of Pseudomonas aeruginosa in clinical samples","volume":"43","author":"Kodaka","year":"2003","journal-title":"J Basic Microbiol"},{"issue":"suppl 4","key":"10.1111\/j.1469-0691.2007.01681.x_bib86","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1086\/500662","article-title":"Overview of the epidemiological profile and laboratory detection of extended\u2010spectrum beta\u2010lactamases","volume":"42","author":"Pfaller","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib87","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/JCM.44.3.1101-1104.2006","article-title":"Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad\u2010spectrum beta\u2010lactam agents","volume":"44","author":"Sader","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib88","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1128\/JCM.39.9.3247-3253.2001","article-title":"Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram\u2010negative rods frequently isolated from clinical samples","volume":"39","author":"Joyanes","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/acb.2005.002","article-title":"Susceptibility testing of Pseudomonas aeruginosa by the Vitek 2 system: a comparison with Etest results","volume":"60","author":"Saegeman","year":"2005","journal-title":"Acta Clin Belg"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib90","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1128\/JCM.35.8.2115-2119.1997","article-title":"Multicenter laboratory evaluation of the bioMerieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa","volume":"35","author":"Doern","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dki303","article-title":"Simple method to determine \u03b2\u2010lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test","volume":"56","author":"Vedel","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1574-6968.2005.00008.x","article-title":"Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real\u2010time\u2010PCR","volume":"254","author":"Dumas","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib93","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkl266","article-title":"Characterization of acquired \u03b2\u2010lactamases and their genetic support in multidrug\u2010resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons","volume":"58","author":"Yan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib94","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital\u2010acquired, ventilator\u2010associated, and healthcare\u2010associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib95","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","article-title":"1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America","volume":"25","author":"Hughes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib96","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-2006-933675","article-title":"Should antibiotic combinations be used to treat ventilator\u2010associated pneumonia?","volume":"27","author":"Eggimann","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib97","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.idc.2004.08.001","article-title":"Healthcare\u2010associated pneumonia in adults: management principles to improve outcomes","volume":"18","author":"Craven","year":"2004","journal-title":"Infect Dis Clin North Am"},{"issue":"suppl 5","key":"10.1111\/j.1469-0691.2007.01681.x_bib98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-0691.2005.01241.x","article-title":"Advances in the management of pneumonia in the intensive care unit: review of current thinking","volume":"11","author":"Rello","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib99","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator\u2010associated pneumonia","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic\u2010resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib101","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archinte.159.10.1127","article-title":"Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa","volume":"159","author":"Carmeli","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib102","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","article-title":"Diagnosis of ventilator\u2010associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic \u2018blind\u2019 bronchoalveolar lavage fluid","volume":"143","author":"Pugin","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short\u2010course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200666010-00001","article-title":"Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance","volume":"66","author":"DeRyke","year":"2006","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/AAC.40.3.691","article-title":"Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram\u2010negative infections","volume":"40","author":"Benko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib106","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1592\/phco.23.3.291.32110","article-title":"Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa","volume":"23","author":"Tam","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib107","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/AAC.46.8.2327-2332.2002","article-title":"Comparative stability studies of antipseudomonal beta\u2010lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor\u2010operated syringes (intensive care units)","volume":"46","author":"Viaene","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib108","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1179\/joc.1996.8.6.457","article-title":"Efficacy and safety of once\u2010daily amikacin in combination with ceftazidime in critically ill adults with severe gram\u2010negative infections","volume":"8","author":"Fayed","year":"1996","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib109","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta\u2010analysis","volume":"312","author":"Barza","year":"1996","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot\u2010Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib111","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.42.3.521","article-title":"Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy","volume":"42","author":"Thomas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib112","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1086\/503167","article-title":"Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa","volume":"21","author":"Hyatt","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2006-933674","article-title":"Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator\u2010associated pneumonia","volume":"27","author":"Kiem","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0885066603254249","article-title":"Nosocomial pneumonia in the intensive care unit: controversies and dilemmas","volume":"18","author":"Mehta","year":"2003","journal-title":"J Intens Care Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam\u2010aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta\u2010analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib116","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/cc4908","article-title":"Ventilator\u2010associated pneumonia: monotherapy is optimal if chosen wisely","volume":"10","author":"Cunha","year":"2006","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib117","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","article-title":"Pseudomonas bacteremia. Retrospective analysis of 410 episodes","volume":"145","author":"Bodey","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib118","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator\u2010associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib119","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re\u2010emerging antibiotic for multidrug\u2010resistant Gram\u2010negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib121","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MMBR.20.1.14-27.1956","article-title":"The properties and mode of action of polymyxins","volume":"20","author":"Newton","year":"1956","journal-title":"Bacteriol Rev"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib122","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/AAC.45.3.781-785.2001","article-title":"In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis","volume":"45","author":"Li","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib123","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/JCM.39.1.183-190.2001","article-title":"Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines","volume":"39","author":"Gales","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib124","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug\u2010resistant gram\u2010negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib125","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1469-0691.2004.01043.x","article-title":"Colistin treatment in patients with ICU\u2010acquired infections caused by multiresistant Gram\u2010negative bacteria: the renaissance of an old antibiotic","volume":"11","author":"Michalopoulos","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib127","first-page":"1134","article-title":"An 18\u2010case outbreak of drug\u2010resistant Pseudomonas aeruginosa bacteriemia in hematology patients","volume":"91","author":"Micol","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijid.2005.03.005","article-title":"Successful treatment of multidrug\u2010resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin","volume":"10","author":"Schina","year":"2006","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib129","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug\u2010resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/joc.2003.15.3.235","article-title":"In vitro interaction of colistin and rifampin on multidrug\u2010resistant Pseudomonas aeruginosa","volume":"15","author":"Giamarellos\u2010Bourboulis","year":"2003","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib131","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1001\/jama.287.22.2958","article-title":"Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors","volume":"287","author":"West","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib132","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib133","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-143-11-200512060-00010","article-title":"Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria","volume":"143","author":"Starner","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib134","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1469-0691.2005.01217.x","article-title":"Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients","volume":"11","author":"Canton","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/318075","article-title":"Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis","volume":"183","author":"Burns","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib136","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1067\/mpd.2001.112897","article-title":"Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis","volume":"138","author":"Nixon","year":"2001","journal-title":"J Pediatr"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib137","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ppul.1144","article-title":"Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis","volume":"32","author":"Rosenfeld","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib138","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2004.03.008","article-title":"Early intervention and prevention of lung disease in cystic fibrosis: a European consensus","volume":"3","author":"Doring","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ppul.1950190103","article-title":"Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis","volume":"19","author":"Pamukcu","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib141","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.2009.abs","article-title":"Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition","volume":"32","author":"Kosorok","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib143","series-title":"Patient registry 1996 annual data report","author":"Anonymous","year":"1997"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib144","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1569-1993(03)00024-9","article-title":"Cost of care and clinical condition in paediatric cystic fibrosis patients","volume":"2","author":"Baumann","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib145","series-title":"Report of the UK Cystic Fibrosis Trust Antibiotic Group","author":"Anonymous","year":"2002"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib146","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ppul.10135","article-title":"Early infection and progression of cystic fibrosis lung disease","volume":"34","author":"Koch","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib147","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ppul.10401","article-title":"Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center","volume":"37","author":"Lee","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib148","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.0.CO;2-1","article-title":"Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974\u20131995)","volume":"28","author":"Frederiksen","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib149","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(85)92222-6","article-title":"Nebulised colomycin for early Pseudomonas colonisation in cystic fibrosis","volume":"i","author":"Littlewood","year":"1985","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib150","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0140-6736(91)91446-2","article-title":"Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment","volume":"338","author":"Valerius","year":"1991","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib151","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O","article-title":"Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis","volume":"23","author":"Frederiksen","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib152","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.0.CO;2-J","article-title":"Placebo\u2010controlled, double\u2010blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis","volume":"25","author":"Wiesemann","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib153","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(01)06124-4","article-title":"Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis","volume":"358","author":"Ratjen","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib154","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(02)07726-7","article-title":"Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients","volume":"359","author":"Taccetti","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1699-0463.1994.tb05219.x","article-title":"Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center","volume":"102","author":"Ciofu","year":"1994","journal-title":"APMIS"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib156","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ppul.1950080311","article-title":"Lung disease in cystic fibrosis\u2014an updated concept","volume":"8","author":"Zach","year":"1990","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004197.pub2","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","author":"Wood","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib158","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00228-004-0735-2","article-title":"Early antibiotic treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature","volume":"60","author":"Marchetti","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib159","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ppul.10019","article-title":"Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study","volume":"33","author":"Heinzl","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2006.04.001","article-title":"Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"5","author":"Lebecque","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib161","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003088-198713040-00002","article-title":"Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance","volume":"13","author":"De Groot","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib162","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcf.2006.05.009","article-title":"Open follow\u2010up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis","volume":"5","author":"Adeboyeku","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib163","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00001432-200404000-00007","article-title":"Role of nebulized antibiotics for the treatment of respiratory infections","volume":"17","author":"Klepser","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib164","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ppul.1125","article-title":"Efficacy and safety of aerosolized tobramycin in cystic fibrosis","volume":"32","author":"Pai","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001021","article-title":"Nebulised anti\u2010pseudomonal antibiotics for cystic fibrosis","author":"Ryan","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib166","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/cc3036","article-title":"Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug\u2010resistant Gram\u2010negative bacteria in patients without cystic fibrosis","volume":"9","author":"Mubareka","year":"2005","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib167","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/PL00008370","article-title":"Continuous infusion of ceftazidime with a portable pump is as effective as thrice\u2010a\u2010day bolus in cystic fibrosis children","volume":"159","author":"Rappaz","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib168","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/40.1.125","article-title":"Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics","volume":"40","author":"Vinks","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib169","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1345\/aph.18146","article-title":"Clinical use of fluoroquinolones in children","volume":"34","author":"Alghasham","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib170","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/030006059802600604","article-title":"Oral ciprofloxacin in the treatment of Pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning","volume":"26","author":"Redmond","year":"1998","journal-title":"J Int Med Res"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib171","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1099-0496(199707)24:1<42::AID-PPUL7>3.0.CO;2-L","article-title":"Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis","volume":"24","author":"Bosworth","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib172","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thx.2003.005876","article-title":"Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis","volume":"59","author":"Thornton","year":"2004","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib173","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bcp.2005.09.018","article-title":"Unmet medical needs in antibacterial therapy","volume":"71","author":"Rice","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2007.01681.x_bib174","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1469-0691.2006.01403.x","article-title":"Can beta\u2010lactams be re\u2010engineered to beat MRSA?","volume":"12","author":"Livermore","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2003.09.006","article-title":"In vitro activity of BAL9141 against clinical isolates of gram\u2010negative bacteria","volume":"48","author":"Issa","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib176","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.49.6.2510-2511.2005","article-title":"In vitro activity of doripenem (S\u20104661) against multidrug\u2010resistant gram\u2010negative bacilli isolated from patients with cystic fibrosis","volume":"49","author":"Chen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib177","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/AAC.48.8.3086-3092.2004","article-title":"Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential","volume":"48","author":"Mushtaq","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib178","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.50.2.819-821.2006","article-title":"In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non\u2010cystic fibrosis patients","volume":"50","author":"Traczewski","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib179","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.49.9.3944-3947.2005","article-title":"Use of pharmacokinetic\u2010pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem","volume":"49","author":"Bhavnani","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib180","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1128\/AAC.39.7.1467","article-title":"Contribution of the C\u20108 substituent of DU\u20106859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa","volume":"39","author":"Kitamura","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib181","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-8579(00)00344-7","article-title":"An open, randomised, multi\u2010centre study comparing the safety and efficacy of sitafloxacin and imipenem\/cilastatin in the intravenous treatment of hospitalised patients with pneumonia","volume":"17","author":"Feldman","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib182","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14787210.4.1.9","article-title":"Tigecycline: a novel glycylcycline antibiotic","volume":"4","author":"Zhanel","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib183","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/dki291","article-title":"Tigecycline: what is it, and where should it be used?","volume":"56","author":"Livermore","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib184","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","article-title":"Efflux\u2010mediated resistance to tigecycline (GAR\u2010936) in Pseudomonas aeruginosa PAO1","volume":"47","author":"Dean","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2005.10.021","article-title":"Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view","volume":"71","author":"Lynch","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib186","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157489106777452692","article-title":"Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux","volume":"1","author":"Van Bambeke","year":"2006","journal-title":"Rec Patents Antiinfect Drug Discov"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib187","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1016\/j.bmcl.2003.07.027","article-title":"MexAB\u2013OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds","volume":"13","author":"Nakayama","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib188","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib189","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.vaccine.2003.11.028","article-title":"Pseudomonas immunotherapy: a historical overview","volume":"22","author":"Holder","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib190","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/14712598.5.7.967","article-title":"Pseudomonas aeruginosa: the potential to immunise against infection","volume":"5","author":"Sedlak\u2010Weinstein","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib191","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcf.2004.10.003","article-title":"Immunisation in the current management of cystic fibrosis patients","volume":"4","author":"Malfroot","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib192","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.130.1.251","article-title":"Preventing ventilator\u2010associated pneumonia in adults: sowing seeds of change","volume":"130","author":"Craven","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib193","series-title":"Principles and practice of infectious diseases","first-page":"634","article-title":"Tables of antimicrobial agents pharmacology","author":"Amsden","year":"2005"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib194","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(84)90358-9","article-title":"Association of aminoglycoside plasma levels with therapeutic outcome in gram\u2010negative pneumonia","volume":"77","author":"Moore","year":"1984","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijantimicag.2006.03.022","article-title":"Intrapulmonary pharmacokinetics and pharmacodynamics of high\u2010dose levofloxacin in healthy volunteer subjects","volume":"28","author":"Conte","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib196","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2\u2010Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib197","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB\u2013OprM, MexCD\u2013OprJ, and MexXY\u2013OprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01681.x_bib198","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.44.3.658-664.2000","article-title":"Assignment of the substrate\u2010selective subunits of the MexEF\u2013OprN multidrug efflux pump of Pseudomonas aeruginosa","volume":"44","author":"Maseda","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14622229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14622229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T23:35:57Z","timestamp":1587339357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14622229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":198,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1198743X14622229"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01681.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}